Director of The Parker Institute for Cancer Research, Regental Professor and Chair of the Department of Immunology
Immunology, Immunotherapy
EDUCATION
BS/PhD – The University of Texas, Austin
Postdoctoral Fellow – Molecular Immunology, Scripps Clinic and Research Foundation
AWARDS AND ACCOLADES
Nobel Prize in Physiology or Medicine (2018)
Paul Janssen Award for Biomedical Research (2018)
Wolf Prize for Medicine (2017)
Lasker-DeBakey Clinical Medical Research Award (2015)
Canada Gairdner International Award (2014)
Breakthrough Prize in Life Sciences (2014)
COMPANIES AND BOARDS
Co-Founder – Jounce Therapeutics, Neon
Scientific Advisory Board – Achelios, Affini-T, Apricity, Asher Bio, Bio Alta, LLC, Candel Therapeutics, Carisma, Codiak Biosciences, C-Reveal Therapeutics, Dragonfly Therapeutics, Earli Inc, Enable Medicine, Glympse Bio, Henlius/Hengenix, Hummingbird, ImaginAB, Infinity Pharma, InterVenn Biosciences, Lava Therapeutics, Lytix BioPharma, Marker Therapeutics, Oncolytics, PBM Capital, Phenomic AI, Polaris Pharma, Trained Therapeutix Discovery, Two Bear Capital, Xilis, Inc.